Median survival was 28 months (95% CI: 18. 49-37.50) in the intermediate-risk GS group and 96 months (95% CI: 49.13-142.86) in the high-risk GS group. There was no statistically significant difference between the GS groups in terms of OS as assessed by the Kaplan-Meier method (p-value: 0.156).